Skip to main content
Figure 2 | Genome Biology

Figure 2

From: Novel genes dramatically alter regulatory network topology in amphioxus

Figure 2

The diversification of the innate immune arsenal in amphioxus. (a) A simplified model of extracellular and intracellular innate immune signaling in human. TLR signaling involves recruitment of a number of TIR domain-containing adaptors, including myeloid differentiation factor 88 (MyD88), TIR domain-containing adaptor protein (TIRAP), TIR domain-containing adaptor inducing interferon-β (TRIF), TRIF-related adaptor molecule (TRAM), and sterile α and HEAT-Armadillo motifs containing protein (SARM), which in turn activates transcription factors such as nuclear factor-κB (NF-κB) and interferon regulatory factors (IRFs) that ultimately lead to tumor necrosis factor (TNF) and type I interferon (IFN) production. NLR signaling can also stimulate inflammatory responses via the NF-κB pathway. Also, NLRs can form the inflammasome with apoptosis-associated speck-like protein (ASC) and procaspase-1, leading to the generation of the active form of interleukin (IL)-1β and IL-18. (b) The diversity of the innate immune system in amphioxus. Novel domain architectures as well as significant expansion in receptor number are evident. Selected 'direct connection' gene models are shown against a pink background. The cellular localization of amphioxus TLR proteins is still unclear; some of them could be localized in endosome in a manner equivalent to that seen in mammals. Domains: BIR, baculovirus inhibitor of apoptosis repeat domain [1]; CARD, caspase recruitment domain [1]; CASPASE, caspase [1]; DD, death domain [1]; DED, death effector domain [1]; IPAF, ICE (IL-1β converting enzyme) protease activating factor; LRR, leucine-rich repeat [24]; NACHT, NAIP, CIITA, HET-E, and TP1 [28]; NALP, NACHT, LRR, and PYRIN-domain-containing protein; NB-ARC, nucleotide-binding adaptor shared by APAF-1, R proteins, and CED-4 [42]; PYRIN, amino-terminal domain of protein pyrin [1]; TIR, Toll/interleukin-1 receptor [3, 26]; TNFR, tumor necrosis factor receptor [59]; WD40, Trp-Asp 40 [60].

Back to article page